The blood thinner Pradaxa (dabigatran) causes more major bleeding events including gastrointestinal bleeding than the commonly used warfarin, but fewer brain bleeds occurred in Pradaxa users compared to warfarin users, according to a new study. Pradaxa was approved in 2010 by the Food and Drug Administration (FDA) to prevent strokes and blood clots in patients with a common type of abnormal heart rhythm known as atrial fibrillation, a condition that can cause strokes. Pradaxa was the first in a new class of anticoagulants, and the first to go head-to-head against the long-prescribed warfarin for stroke prevention in atrial fibrillation patients. ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.